Literature DB >> 8202877

Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

W A Wallace1, S N Roberts, H Caldwell, E Thornton, A P Greening, D Lamb, S E Howie.   

Abstract

BACKGROUND: It has been hypothesised that cryptogenic fibrosing alveolitis has an immunological pathogenesis mediated by T lymphocytes. It is, however, recognised that patients may show dysregulation of the humoral immune system and that the presence of large numbers of B lymphocytes in open lung biopsies may be associated with a poor prognosis. Evidence of a role for the humoral immune system in the pathogenesis of cryptogenic fibrosing alveolitis has been suggested, but attempts to demonstrate circulating immunoglobulin to antigen within the lung have been inconclusive.
METHODS: Plasma samples from 22 patients with cryptogenic fibrosing alveolitis, 22 patients with sarcoidosis, and 17 healthy controls were screened by SDS-PAGE and Western blotting for the presence of autoantibodies to lung proteins derived from cryptogenic fibrosing alveolitis, sarcoid and control lung tissue, as well as four normal non-pulmonary tissues. Possible site(s) of target protein(s) within the lung tissue were identified by immunohistochemical examination using IgG purified from the plasma of six patients and two controls.
RESULTS: Eighteen of the plasma samples from patients with cryptogenic fibrosing alveolitis had reactive IgG to lung protein(s) in the 70-90 kDa molecular weight range compared with five of 18 plasma samples from patients with sarcoidosis and one of 17 controls. Plasma from patients with cryptogenic fibrosing alveolitis recognised antigen(s) of the same molecular weight in control and sarcoid lung tissue, but not non-pulmonary tissues, with a similar frequency. Immunohistochemical staining of cryptogenic fibrosing alveolitis biopsy material using IgG purified from plasma samples from patients with cryptogenic fibrosing alveolitis, but not control samples, revealed fine linear positivity in the lung parenchyma in a pattern suggestive of reaction with alveolar lining cells. The pattern was cytoplasmic/membranous and not nuclear.
CONCLUSIONS: Patients with cryptogenic fibrosing alveolitis have a high frequency of plasma IgG autoantibodies to protein(s) within lung tissue associated with alveolar lining cells. This is believed to be the site where immunological injury occurs in cryptogenic fibrosing alveolitis, but the significance of these antibodies to the aetiology and pathogenesis is as yet unclear.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202877      PMCID: PMC1021149          DOI: 10.1136/thx.49.3.218

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  AUTO-ANTIBODY STUDIES IN INTERSTITIAL PULMONARY FIBROSIS.

Authors:  M TURNER-WARWICK; D DONIACH
Journal:  Br Med J       Date:  1965-04-03

2.  Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.

Authors:  P L Haslam; B Thompson; I Mohammed; P J Townsend; M E Hodson; E J Holborow; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

3.  Immunofluorescent patterns in the idiopathic interstitial pneumonias.

Authors:  M I Schwarz; R B Dreisin; D S Pratt; R E Stanford
Journal:  J Lab Clin Med       Date:  1978-06

4.  Usual interstitial pneumonitis is a T-cell alveolitis.

Authors:  R L Kradin; M B Divertie; R B Colvin; J Ramirez; J Ryu; H A Carpenter; A K Bhan
Journal:  Clin Immunol Immunopathol       Date:  1986-08

5.  Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.

Authors:  D A Campbell; L W Poulter; G Janossy; R M du Bois
Journal:  Thorax       Date:  1985-06       Impact factor: 9.139

6.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-08       Impact factor: 9.139

8.  Immunohistological study of human lungs by immunoperoxidase technique.

Authors:  B Fox; S Shousha; K R James; G C Miller
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

9.  Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis.

Authors:  B Corrin; A Dewar; R Rodriguez-Roisin; M Turner-Warwick
Journal:  J Pathol       Date:  1985-10       Impact factor: 7.996

10.  Does de novo immunoglobulin synthesis occur on the epithelial surface of the human lower respiratory tract?

Authors:  A J Hance; C Saltini; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1988-01
View more
  15 in total

Review 1.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 2.  Idiopathic pulmonary fibrosis and a role for autoimmunity.

Authors:  Gerard F Hoyne; Hannah Elliott; Steven E Mutsaers; Cecilia M Prêle
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

3.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

4.  Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; J A Schofield; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

5.  A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA).

Authors:  W A Wallace; E A Ramage; D Lamb; S E Howie
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

6.  Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies.

Authors:  Ahmed Fahim; Mei C Chong; Michael G Crooks; Simon P Hart
Journal:  Lung       Date:  2012-05-16       Impact factor: 2.584

7.  Molecular and cellular mechanisms of pulmonary fibrosis.

Authors:  Nevins W Todd; Irina G Luzina; Sergei P Atamas
Journal:  Fibrogenesis Tissue Repair       Date:  2012-07-23

8.  Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  C Robinson; M Callow; S Stevenson; B W Robinson; R A Lake
Journal:  Respir Res       Date:  2001-02-20

9.  Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.

Authors:  Stylianos Bournazos; Jacob Grinfeld; Karen M Alexander; John T Murchison; William A Wallace; Pauline McFarlane; Nikhil Hirani; A John Simpson; Ian Dransfield; Simon P Hart
Journal:  BMC Pulm Med       Date:  2010-10-07       Impact factor: 3.317

10.  Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis.

Authors:  Stylianos Bournazos; Irini Bournazou; John T Murchison; William A Wallace; Pauline McFarlane; Nikhil Hirani; A John Simpson; Ian Dransfield; Simon P Hart
Journal:  Lung       Date:  2010-10-06       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.